JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$1.56B |
| 2 |
JPMorgan BetaBuilders Japan ETF
BBJP
|
+$1.56B |
| 3 |
iShares 1-3 Year Treasury Bond ETF
SHY
|
+$1.17B |
| 4 |
iShares S&P 500 Value ETF
IVE
|
+$777M |
| 5 |
iShares S&P 500 Growth ETF
IVW
|
+$762M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$6.82B |
| 2 |
iShares Core MSCI EAFE ETF
IEFA
|
+$1.38B |
| 3 |
Apple
AAPL
|
+$977M |
| 4 |
iShares MSCI EAFE ETF
EFA
|
+$915M |
| 5 |
Walt Disney
DIS
|
+$778M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 12.46% |
| 2 | Technology | 11.62% |
| 3 | Healthcare | 10.99% |
| 4 | Consumer Discretionary | 8.24% |
| 5 | Industrials | 7.12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3476
Viridian Therapeutics
VRDN
$2.09B
| $1.19M | ﹤0.01% |
26,141
+1,944
| +8% | +$112K |
|
3477
Ormat Technologies
ORA
$6B
| $1.19M | ﹤0.01% |
22,692
+5,545
| +32% | +$292K |
|
|
SGMO
3478
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
| $1.19M | ﹤0.01% |
103,436
-2,275
| -2% | -$28.3K |
|
|
BGX
3479
Blackstone Long-Short Credit Income Fund
BGX
$136M
| $1.18M | ﹤0.01% |
86,158
+6,750
| +9% | +$103K |
|
|
EFII
3480
DELISTED
Electronics for Imaging
EFII
| $1.18M | ﹤0.01% |
47,611
-1,213
| -2% | -$35K |
|
3481
TG Therapeutics
TGTX
$7.96B
| $1.18M | ﹤0.01% |
287,718
-16,779
| -6% | -$83.4K |
|
3482
CALL
Deere & Co
DE
$160B
| $1.18M | ﹤0.01% |
7,900
-14,000
| -64% | -$2.05M |
|
3483
CALL
Ironwood Pharmaceuticals
IRWD
$696M
| $1.18M | ﹤0.01% |
+135,638
| New | +$1.56M |
|
|
BKS
3484
DELISTED
Barnes & Noble
BKS
| $1.17M | ﹤0.01% |
165,632
+145,745
| +733% | +$974K |
|
|
ORIT
3485
DELISTED
Oritani Financial Corp. New
ORIT
| $1.17M | ﹤0.01% |
79,431
+2,662
| +3% | +$40.2K |
|
|
AC
3486
DELISTED
Associated Capital Group
AC
| $1.17M | ﹤0.01% |
33,369
+9,246
| +38% | +$369K |
|
|
FRGI
3487
DELISTED
Fiesta Restaurant Group, Inc.
FRGI
| $1.17M | ﹤0.01% |
75,293
+40,634
| +117% | +$886K |
|
3488
Takeda Pharmaceutical
TAK
$54.6B
| $1.16M | ﹤0.01% |
+69,178
| New | +$1.17M |
|
3489
Pan American Silver
PAAS
$18.2B
| $1.16M | ﹤0.01% |
79,336
-120,827
| -60% | -$1.73M |
|
3490
AtriCure
ATRC
$1.92B
| $1.16M | ﹤0.01% |
37,859
+15,672
| +71% | +$488K |
|
3491
CALL
Eversource Energy
ES
$26.9B
| $1.16M | ﹤0.01% |
+17,800
| New | +$1.16M |
|
3492
News Corp Class B
NWS
$16.9B
| $1.16M | ﹤0.01% |
100,207
+45,671
| +84% | +$597K |
|
|
SIEN
3493
DELISTED
Sientra, Inc.
SIEN
| $1.16M | ﹤0.01% |
9,103
-7,286
| -44% | -$1.35M |
|
3494
MGP Ingredients
MGPI
$379M
| $1.16M | ﹤0.01% |
20,264
+10,988
| +118% | +$742K |
|
3495
Otter Tail
OTTR
$3.71B
| $1.15M | ﹤0.01% |
23,193
+9,629
| +71% | +$460K |
|
|
AVID
3496
DELISTED
Avid Technology Inc
AVID
| $1.15M | ﹤0.01% |
242,284
+96,414
| +66% | +$556K |
|
|
XRN
3497
Chiron Real Estate Inc
XRN
$514M
| $1.15M | ﹤0.01% |
25,803
+4,306
| +20% | +$198K |
|
3498
Spero Therapeutics
SPRO
$67.7M
| $1.15M | ﹤0.01% |
186,176
+9,693
| +5% | +$78.5K |
|
3499
Innovative Industrial Properties
IIPR
$1.71B
| $1.14M | ﹤0.01% |
25,195
-23,093
| -48% | -$1.06M |
|
3500
Mueller Water Products
MWA
$3.95B
| $1.14M | ﹤0.01% |
125,538
-30,052
| -19% | -$315K |
|
Similar funds
JP Morgan Chase's Q4 2018 Portfolio in Review
As of Q4 2018, JP Morgan Chase held 6,191 positions worth $432B, down 17% from $522B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
JP Morgan Chase withdrew a net $17.1B in Q4 2018, closing 424 positions and reducing 2,219 holdings. Its most notable exit was Energen, an estimated $648M position sold in full.
By sector, the portfolio is most concentrated in Financials at 12% of assets, down from 13% a quarter earlier, followed by Technology and Healthcare.
Against the trend, JP Morgan Chase opened a new position in Linde worth $751M.
- JP Morgan Chase's largest Q4 2018 buy was Linde: 4,813,392 shares worth $751M.
- JP Morgan Chase added most to JPMorgan BetaBuilders Europe ETF in Q4 2018, an estimated $1.56B increase.
- JP Morgan Chase's biggest Q4 2018 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $6.82B.
- JP Morgan Chase fully exited Energen in Q4 2018, selling an estimated $648M.
- JP Morgan Chase's ten largest holdings make up 16% of its $432B portfolio in Q4 2018.
- JP Morgan Chase opened 487 new positions and closed 424 in Q4 2018.
- JP Morgan Chase's portfolio value fell 17% quarter-over-quarter to $432B.
Based on JP Morgan Chase's 13F filing for Q4 2018, filed 11 Feb 2019.